Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery

AbstractPurpose. The aim of this study was to prepare a novel vaccine carrier particulate system (nanoparticles and emulsions) with chitosan and to evaluate the effect of this system on the immune response for intranasal delivery. Methods. Chitosan nanoparticles (NP) and chitosan-coated emulsions (CC-Emul) were prepared by improvement of the method previously reported and by modified ethanol injection methods, respectively. The rats were immunized with the particles adsorbed with ovalbumin (OVA) and cholera toxin (CT) by intranasal (i.n.) and intraperitoneal (i.p.) administration. Results. NP and CC-Emul could be prepared with particle diameter from about 0.4 μm to 3 μm. IgG induced by i.n. of NP was comparable with that by i.p., and IgA induced by i.n. of 0.4-μm- and 1-μm-size NP was significantly higher than control (OVA and CT). IgG and IgA induced by i.n. of 2-μm-size CC-Emul were significantly higher than those with control. Conclusions. The novel chitosan particles used simple preparation methods showed high OVA adsorption. When administered intranasally, NP and CC-Emul induced systemic immune response in rats. These findings suggested that CC-Emul and the smaller-size (0.4 μm) NP are effective for targeting to nasal-associated lymphoid tissues (NALTs) in nasal vaccine delivery.

[1]  A. Almeida,et al.  Nasal delivery of vaccines. , 1996, Journal of drug targeting.

[2]  E. Hundt,et al.  Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice , 2001, Pharmaceutical Research.

[3]  H E Junginger,et al.  Chitosan and its derivatives in mucosal drug and vaccine delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Y. Maitani,et al.  MODIFIED ETHANOL INJECTION METHOD FOR LIPOSOMES CONTAINING β-SITOSTEROL β-D-GLUCOSIDE , 2001, Journal of liposome research.

[5]  I. Azuma,et al.  Adjuvant activity of chitin derivatives in mice and guinea-pigs. , 1985, Vaccine.

[6]  T. Uchida,et al.  Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. , 1994, Biological & pharmaceutical bulletin.

[7]  F. Ennis,et al.  IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. , 1999, Journal of immunology.

[8]  H E Junginger,et al.  Chitosan for mucosal vaccination. , 2001, Advanced drug delivery reviews.

[9]  J. Wilschut,et al.  Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. , 1995, Vaccine.

[10]  J. Kraehenbuhl,et al.  Antigen sampling across epithelial barriers and induction of mucosal immune responses. , 1996, Annual review of immunology.

[11]  H E Junginger,et al.  In Vivo Uptake of Chitosan Microparticles by Murine Peyer's Patches: Visualization Studies using Confocal Laser Scanning Microscopy and Immunohistochemistry , 2001, Journal of drug targeting.

[12]  A. Perkins,et al.  Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.